Revolutionary Blood Test Could Predict Alzheimer's Decades Before Symptoms

A new blood test may soon help predict Alzheimer's years before symptoms appear. Researchers have developed a method to detect elevated levels of a protein linked to the disease. This could change how early diagnoses are made and how treatments are tested.

The test measures p-tau217, a protein tied to the buildup of amyloid and tau in the brain. High levels at age 60 suggest symptoms might develop around 20 years later. If detected at 80, symptoms could still take 11 years to appear.

Trials show the test predicts symptom onset within a three-to-four-year margin of error. This precision could make clinical trials more efficient by identifying participants likely to develop Alzheimer's within a set timeframe. Currently, over 7 million Americans live with the disease, a number expected to nearly double by 2040.

Alzheimer's remains a leading cause of death for those over 65, ranking sixth in 2022. Life expectancy after diagnosis at 65 averages four to eight years, though some survive up to two decades. The disease affects about one in nine people in that age group, with women making up two-thirds of cases.

The blood test offers a potential breakthrough in early detection, though its widespread adoption remains unclear. With Alzheimer's cases rising, improved diagnostics could help researchers and doctors intervene sooner. The test's accuracy in forecasting symptom onset may also speed up the search for new treatments.